PD-1/PD-L1 Are Novel Therapeutic Targets for Mastocytosis

被引：0
|
作者：
Geeze, Mary
Hatch, Ellen
Martin, Cheyenne
Perkins, Sherrie L.
Hartmann, Karin
Valent, Peter
Gotlib, Jason
Lidke, Diane
George, Tracy I.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Med Univ Lubeck, D-23538 Lubeck, Germany
[4] Med Univ Vienna, Vienna, Austria
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1371
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [31] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [32] High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
    Sanchez-Magraner, Lissete
    Miles, James
    Baker, Claire L.
    Applebee, Christopher J.
    Lee, Dae-Jin
    Elsheikh, Somaia
    Lashin, Shaimaa
    Withers, Katriona
    Watts, Andrew G.
    Parry, Richard
    Edmead, Christine
    Lopez, Jose Ignacio
    Mehta, Raj
    Italiano, Antoine
    Ward, Stephen G.
    Parker, Peter J.
    Larijani, Banafshe
    CANCER RESEARCH, 2020, 80 (19) : 4244 - 4257
  • [33] Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis
    Tabana, Yasser
    Okoye, Isobel S.
    Siraki, Arno
    Elahi, Shokrollah
    Barakat, Khaled H.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring
    Pizon, M.
    Schott, D.
    Pachmann, U.
    Pachmann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [35] The PD-1/PD-L1 Pathway in Human Pathology
    Saresella, M.
    Rainone, V.
    Al-Daghri, N. M.
    Clerici, M.
    Trabattoni, D.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 259 - 267
  • [36] PD-1/PD-L1 as a prognostic factor in leukemia
    Hadi Rezaeeyan
    Seyedeh Nafiseh Hassani
    Mojgan Barati
    Mohammad Shahjahani
    Najmaldin Saki
    Journal of Hematopathology, 2017, 10 : 17 - 24
  • [37] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [38] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    LABORATORY INVESTIGATION, 2019, 99
  • [39] The PD-1:PD-L1 axis in Inflammatory Arthritis
    Mary Canavan
    Achilleas Floudas
    Douglas J. Veale
    Ursula Fearon
    BMC Rheumatology, 5
  • [40] Regulatory mechanisms of PD-1/PD-L1 in cancers
    Lin, Xin
    Kang, Kuan
    Chen, Pan
    Zeng, Zhaoyang
    Li, Guiyuan
    Xiong, Wei
    Yi, Mei
    Xiang, Bo
    MOLECULAR CANCER, 2024, 23 (01)
12345